D K Bartsch Selected Research

D K Bartsch Research Topics

Disease

21	Neoplasms (Cancer) 09/2022 - 01/2000
7	Pancreatic Neoplasms (Pancreatic Cancer) 10/2013 - 01/2000
6	Neoplasm Metastasis (Metastasis) 05/2017 - 01/2005
4	Carcinogenesis 10/2014 - 01/2000
4	Gastrinoma 09/2012 - 01/2000
3	Carcinoma (Carcinomatosis) 09/2022 - 08/2017
2	Lymphatic Metastasis 09/2022 - 06/2014
2	Pheochromocytoma 09/2022 - 04/2012
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 05/2021 - 11/2019
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2013 - 07/2006
2	Chronic Pancreatitis 01/2011 - 04/2001
2	Multiple Endocrine Neoplasia Type 1 12/2006 - 09/2004
2	Insulinoma 04/2004 - 01/2000
1	Thrombosis (Thrombus) 09/2022
1	Adrenocortical Carcinoma 09/2022
1	Neuroblastoma 09/2022
1	Neurilemmoma (Schwannoma) 09/2022
1	Thyroid Diseases (Thyroid Disease) 09/2018
1	Anaplastic Thyroid Carcinoma 01/2016
1	Islet Cell Adenoma (Islet Cell Tumors) 10/2014
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2014
1	Rupture 06/2014
1	Neoplasms, Cystic, Mucinous, and Serous 03/2013
1	Hypertension (High Blood Pressure) 04/2012
1	Anastomotic Leak 01/2012
1	Pancreatitis 01/2011
1	Chronic Renal Insufficiency 08/2010
1	Thyroid Nodule (Nodule, Thyroid) 08/2010
1	Thyroid Neoplasms (Thyroid Cancer) 08/2010
1	Vipoma (WDHA) 02/2009
1	Glucagonoma 02/2009
1	Carcinoid Tumor (Carcinoid) 09/2007
1	Adrenocortical Adenoma (Disease, Conn's) 04/2006
1	Hyperinsulinism (Hyperinsulinemia) 03/2005
1	Primary Hyperparathyroidism 09/2004
1	Cushing Syndrome 09/2002
1	Hyperplasia 09/2002
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2000
1	Islet Cell Carcinoma 11/2000

Drug/Important Bio-Agent (IBA)

4	Indicators and Reagents (Reagents)IBA 03/2013 - 11/2000
3	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2006 - 11/2000
2	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 11/2000
2	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2001 - 01/2000
1	Pharmaceutical PreparationsIBA 01/2016
1	Enalapril FDA LinkGeneric 10/2014
1	AngiotensinsIBA 10/2014
1	EnzymesIBA 10/2014
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2014
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2014
1	Capsules (Microcapsules)IBA 06/2014
1	Gemcitabine FDA Link 10/2013
1	Cetuximab (Erbitux)FDA Link 10/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	SirtuinsIBA 09/2012
1	GastrinsIBA 09/2012
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2011
1	Kazal Pancreatic Trypsin InhibitorIBA 01/2011
1	TrypsinogenIBA 01/2011
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2011
1	chymotrypsin CIBA 01/2011
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 08/2010
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 02/2009
1	Nonsense Codon (Nonsense Mutation)IBA 09/2007
1	Complementary DNA (cDNA)IBA 04/2006
1	Chromogranin BIBA 04/2006
1	RNA (Ribonucleic Acid)IBA 04/2006
1	C-PeptideIBA 03/2005
1	Blood Glucose (Blood Sugar)IBA 03/2005
1	Insulin (Novolin)FDA Link 03/2005
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2002
1	Hematoxylin (Haematoxylon)IBA 04/2001
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2001
1	Cysteine (L-Cysteine)FDA Link 01/2000

Therapy/Procedure

8	Therapeutics 06/2019 - 11/2000
4	Lymph Node Excision (Lymph Node Dissection) 05/2020 - 09/2012
3	Lasers (Laser) 05/2017 - 05/2014
2	Parathyroidectomy 05/2021 - 11/2019
2	Combined Modality Therapy 05/2020 - 01/2016
2	Thyroidectomy 05/2020 - 09/2018
2	Pancreaticoduodenectomy 01/2012 - 01/2005
2	Pancreatectomy 01/2006 - 03/2005
1	Adrenalectomy 09/2022
1	Drug Therapy (Chemotherapy) 05/2020
1	Contraindications 08/2017
1	Adjuvant Chemotherapy 10/2013
1	Radiotherapy 09/2012
1	Homologous Transplantation 01/2005
1	Colectomy 01/2005
1	Vascular Surgical Procedures 04/2004